About CytoKi Pharma
CytoKi Pharma is a company based in Værløse (Denmark) founded in 2019 by Rasmus Jorgensen. CytoKi Pharma has raised $45.02 million across 2 funding rounds from investors including Lundbeck Foundation, Seventure Partners and Ysios Capital. The company has 4 employees as of December 31, 2022. CytoKi Pharma offers products and services including CK-0045. CytoKi Pharma operates in a competitive market with competitors including Aclaris Therapeutics, Sana Biotechnology, Semma Therapeutics, Adocia and Altimmune, among others.
- Headquarter Værløse, Denmark
- Employees 4 as on 31 Dec, 2022
- Founders Rasmus Jorgensen
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytoki Pharma Aps
-
Annual Revenue
Not available
-
Net Profit
-$13.94 M (USD)-231as on Dec 31, 2022
-
EBITDA
-$14.71 M (USD)-192as on Dec 31, 2022
-
Total Equity Funding
$45.02 M (USD)
in 2 rounds
-
Latest Funding Round
$45 M (USD), Series A
May 05, 2021
-
Investors
Lundbeck Foundation
& 3 more
-
Employee Count
4
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CytoKi Pharma
CytoKi Pharma offers a comprehensive portfolio of products and services, including CK-0045.
Long-acting IL-22 analogue for treating metabolic and inflammatory conditions
People of CytoKi Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of CytoKi Pharma
CytoKi Pharma has successfully raised a total of $45.02M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $45 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CytoKi Pharma
CytoKi Pharma has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Lundbeck Foundation, Seventure Partners and Ysios Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science companies are funded through venture capital investments.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Locked | Locked | Locked | |
|
Ysios Capital is recognized as a leading life sciences investor.
|
Locked | Locked | Locked |
Investor details for CytoKi Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CytoKi Pharma
Investment portfolio details for CytoKi Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CytoKi Pharma
Detailed financials for CytoKi Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytoki Pharma Comparisons
Peer comparison for CytoKi Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CytoKi Pharma
CytoKi Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, Sana Biotechnology, Semma Therapeutics, Adocia and Altimmune, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel dermatologic therapies are developed for skin conditions.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
Detailed competitors of CytoKi Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytoki Pharma
Complete news archive for CytoKi Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CytoKi Pharma
CytoKi Pharma was founded in 2019 and raised its 1st funding round 2 years after it was founded.
CytoKi Pharma is headquartered in Værløse, Denmark.
Rasmus Jorgensen is the current CEO of CytoKi Pharma. They have also founded this company.
CytoKi Pharma is a funded company, having raised a total of $45.02M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at CytoKi Pharma is 4.
CytoKi Pharma was founded in 2019 and is based in Vaerlose, Denmark. Operations focus on the biotechnology sector, where engineered biologics are developed to address epithelial-based diseases. The lead product employs IL22 to target non-hematopoietic epithelial and stromal cells. Tissue damage is reduced, repair is stimulated, inflammation is controlled, and fibrosis-free recovery is supported through promotion of cell survival, proliferation, and regeneration.
CytoKi Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
CytoKi Pharma offers CK-0045.
CytoKi Pharma has 4 investors. Key investors include Lundbeck Foundation, Seventure Partners, Ysios Capital, and ND Capital.
The valuation of CytoKi Pharma is $5.64M as of Apr 2021.